Survival analysis and classification of death in patients under anti-arrhythmic treatment.
作者信息
Ector H, Heidbüchel H, Van De Werf F
机构信息
University Hospital Gathuisberg, Leuven, Belgium.
出版信息
Eur Heart J. 1998 Mar;19(3):377-81.
PMID:9568440
Abstract
摘要
相似文献
1
Survival analysis and classification of death in patients under anti-arrhythmic treatment.抗心律失常治疗患者的生存分析与死亡分类
Eur Heart J. 1998 Mar;19(3):377-81.
2
3
Antiarrhythmic trials: a decade of growth.抗心律失常试验：十年发展历程
Indian Heart J. 1998 May-Jun;50(3):277-84.
4
Lessons learned from neutral ICD trials.
Europace. 2006 Jun;8(6):393-7. doi: 10.1093/europace/eul040. Epub 2006 May 2.
5
The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.临床试验的提前终止：原因、后果及控制。特别提及心律失常和心脏性猝死领域的试验。欧洲心脏病学会心律失常工作组特别工作组
Eur Heart J. 1994 Jun;15(6):721-38.
6
[Cardiac Arrhythmia Suppression Trial: a disappointment?].[心律失常抑制试验：令人失望？]
Arq Bras Cardiol. 1990 Sep;55(3):153-4.
7
Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.他汀类药物治疗对非缺血性扩张型心肌病患者心律失常事件及生存率的影响。
J Am Coll Cardiol. 2006 Sep 19;48(6):1228-33. doi: 10.1016/j.jacc.2006.05.053. Epub 2006 Aug 28.
8
Primary prevention of sudden cardiac death: the time of your life.心脏性猝死的一级预防：关乎您生命的时刻。
Circulation. 2004 Mar 9;109(9):1073-5. doi: 10.1161/01.CIR.0000121314.13795.F1.
9
[Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?].
Lakartidningen. 1998 Jan 21;95(4):246-8.
10
[Cardioprotective and anti-arrhythmia omega 3 fatty acids. Protection from sudden cardiac death].
MMW Fortschr Med. 2002 Sep 12;144(37):54.
Zotero 插件